Molina Healthcare Executive Compensation (FY25)
MOH · Executive and director compensation, fiscal 2022 to 2025
The Molina Healthcare brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 12, 2026Latest filing (8-K): May 11, 2026
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
286 figures on this page: 276 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Joseph Zubretsky: $21,944,109 → $18,340,783 (16.4% lower)
CEO pay ratio: 251:1 → 228:1 (9.2% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Molina Healthcare's chief executive and what were they paid?
Joseph Zubretsky was paid $18,340,783 in total compensation as President and Chief Executive Officer for fiscal 2025. Compared with the $21,944,109 reported for fiscal 2024, Zubretsky's total was 16.4% lower.
What was Molina Healthcare's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 52.8% of votes cast for or against in favor at the meeting held May 6, 2026.
Which companies are in Molina Healthcare's peer group?
The disclosed peer group includes Aflac Incorporated, Becton, Dickinson and Company, Boston Scientific Corporation, Centene Corporation and Community Health Systems, Inc., among others.
What is Molina Healthcare's chief executive pay ratio?
The company reported a chief executive pay ratio of 228:1 for fiscal 2025, against median employee compensation of $80,329.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Zubretsky President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Mark Keim Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
James Woys Executive Vice President and Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jeff Barlow Executive Vice President, Chief Legal Officer and Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Zubretsky President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Mark Keim Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
James Woys Executive Vice President and Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jeff Barlow Executive Vice President, Chief Legal Officer and Secretary | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Zubretsky President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Mark Keim Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
James Woys Executive Vice President and Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Denise San Antonio Zeman Executive Vice President and Chief Growth Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jeff Barlow Executive Vice President, Chief Legal Officer and Secretary | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joseph Zubretsky President and Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Mark Keim Chief Financial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
James Woys Chief Operating Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Jeff Barlow Chief Legal Officer and Secretary | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ |
Debra Bacon Executive Vice President, Medicaid | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Debra J. Bacon | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Debra J. Bacon | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| James E. Woys | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| James E. Woys | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Jeff D. Barlow | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Jeff D. Barlow | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Joseph M. Zubretsky | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Joseph M. Zubretsky | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Mark L. Keim | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Mark L. Keim | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Jeff Barlow | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Joseph Zubretsky | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Mark Keim | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| James Woys | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Debra Bacon | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Debra Bacon
Executive Vice President, Medicaid · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
Joseph Zubretsky
President and Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Equity acceleration on change in control | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Mark Keim
Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Dale B. Wolf Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Ronna E. Romney | ◇ | ◇ | — | — | — | — | ◇ |
Steven J. Orlando | ◇ | ◇ | — | — | — | — | ◇ |
Richard M. Schapiro | ◇ | ◇ | — | — | — | — | ◇ |
Richard C. Zoretic | ◇ | ◇ | — | — | — | — | ◇ |
Barbara L. Brasier | ◇ | ◇ | — | — | — | — | ◇ |
Stephen H. Lockhart | ◇ | ◇ | — | — | — | — | ◇ |
Leo P. Grohowski | ◇ | ◇ | — | — | — | — | ◇ |
Daniel Cooperman | ◇ | ◇ | — | — | — | — | ◇ |
Francis S. Soistman and Joseph M. Zubretsky served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
Equity is delivered as Restricted Stock.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Aflac Incorporated AFL
- Becton, Dickinson and Company BDX
- Boston Scientific Corporation BSX
- Centene Corporation CNC
- Community Health Systems, Inc. CYH
- DaVita Inc. DVA
- Elevance Health, Inc. ELV
- HCA Healthcare, Inc. HCA
- Humana, Inc. HUM
- Laboratory Corporation of America Holdings symbol not shown
- MetLife, Inc. MET
- Prudential Financial, Inc. PRU
- Quest Diagnostics Incorporated DGX
- Tenet Healthcare Corporation THC
- The Cigna Group CI
- Universal Health Services, Inc. UHS
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 6, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | April 30, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 1, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 3, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 4, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 6, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 7, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 8, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 2, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 10, 2017 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Molina Healthcare disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Molina Healthcare sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceSay-on-pay responsiveness
Molina Healthcare recorded a low support level. The responsiveness analysis covers what the company said it would do, what it did, and how that compares with the companies that recovered their vote.
Responsiveness analysisAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
286 figures on this page: 276 cited to the filing that reported them, 10 calculated from figures it prints.
276 cited to the filing
10 calculated from the filing
Documents cited
- 0001179929-26-000026
- 0001179929-26-0000142025 Grants of Plan-Based Awards Table · 2025 Non-Employee Director Compensation · 2025 Outstanding Equity Awards at Fiscal Year End Table · 2025 Summary Compensation Table · and 3 more sections
- 0001179929-25-000075
- 0001179929-25-000043Summary Compensation Table
- 0001179929-24-000091
- 0001179929-24-000063Summary Compensation Table
- 0001179929-23-000072
- 0001179929-23-000043Summary Compensation Table
- 0001179929-22-000082
- 0001179929-21-000090
- 0001179929-20-000073
- 0001179929-19-000091
- 0001179929-18-000105
- 0001179929-17-000110
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Molina Healthcare executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/MOH (accessed 2026).
Short form: data: Velarion
The Molina Healthcare brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Molina Healthcare and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Molina Healthcare discloses
The companies named in MOH's own disclosed peer group.
Aflac IncorporatedBecton, Dickinson and CompanyBoston Scientific CorporationCentene CorporationCommunity Health Systems, Inc.DaVita Inc.Elevance Health, Inc.HCA Healthcare, Inc.Humana, Inc.MetLife, Inc.Prudential Financial, Inc.Quest Diagnostics IncorporatedTenet Healthcare CorporationThe Cigna GroupUniversal Health Services, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}